Cryptobrachytone C from Cryptocarya pulchrinervia (Kosterm) Leaves on Proliferation, Apoptosis, Migration and Clonogenicity of MCF-7 and T47D Cell Lines

Main Article Content

Jujun Ratnasari
Marselina Irasonia Tan
Rizkita Rachmi Esyanti
Lia Dewi Juliawaty


Cryptocarya pulchrinervia is an Indonesian indigenous plant that grows in Sumatra, Kalimantan and Papua. One of the new compounds extracted from this plant was cryptobrachytone C, which was known to be cytotoxic against cancer cells of Murine leukemia P388 with IC50 10.52 ?M. In this study, the cytotoxicity and anticancer properties of cryptobrachytone C on proliferation, apoptosis, migration and clone formation of MCF-7 and T47D breast cancer cell lines were examined, which had not previously been done before. The cytotoxicity of the compound was measured using an MTT (3- (4,5-dimethylthiazol-2- yl) -2,5-di-phenyl-tetrazolium bromide) assay. The cell proliferation was measured using a BrdU assay, and the cell apoptosis was measured using annexin-V FITC, while the cell migration was measured using a transwell filter. The cytotoxic test result demonstrated that cryptobrachytone C was cytotoxic against MCF-7 cells with IC50 12.94 ± 0.32 ?M but not against T47D cells with IC50 65.33 ± 2.33 ?M nor against normal MRC-5 cells with IC50 122.57 ± 19.84 ?M. The cell proliferation assay showed that cryptobrachytone C at IC50 concentration had antiproliferative properties against MCF-7 cancer cell lines (p < 0.05) but did not significantly reduce T47D cell proliferation (p < 0.07). Although the results of the cell apoptosis test showed that cryptobrachytone C could induce the apoptosis of the MCF-7 and T47D cells, it was insignificant (p > 0.05). The cell migration test showed that cryptobrachytone at IC50 concentrations could inhibit the migration of the MCF-7 and T47D cells. The clonogenic test showed that cryptobrachytone C at IC50 concentration can induce the inhibition of the formation of MCF-7 and T47D cell colonies. The cryptobrachytone C anti-cancer character was more significant on the MCF-7 cell line compared to the T47D. This study showed that cryptobrachytone C was cytotoxic and had potential as an anti-cancer compound against MCF-7 and T47D breast cancer cell lines.

Article Details

How to Cite
Jujun Ratnasari, Marselina Irasonia Tan, Rizkita Rachmi Esyanti, & Lia Dewi Juliawaty. (2023). Cryptobrachytone C from Cryptocarya pulchrinervia (Kosterm) Leaves on Proliferation, Apoptosis, Migration and Clonogenicity of MCF-7 and T47D Cell Lines . Tropical Life Sciences Research, 34(2), 223–241.
Original Article


Amin A, Gali-Muhtasib H, Ocker M and Schneider-Stock R. (2009). Overview of major classes of plant-derived anticancer drugs. International Journal of Biomedical Science 5(1): 1.

Aubrey B J, Kelly G L, Janic A, Herold M J and Strasser A. (2018). How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell Death & Differentiation 25(1):104–113.

Bailon-Moscoso N, Cevallos-Solorzano G, Carlos Romero-Benavides J and Isabel Ramirez Orellana M. (2017). Natural compounds as modulators of cell cycle arrest: Application for anticancer chemotherapies. Current Genomics 18(2): 106–131.

Boik J. (2001). Natural compounds in cancer therapy. Princeton, MN: Oregon Medical Press.

Calderón-Montano J M, Burgos-Morón E, Orta M L, Pastor N, Austin C A, Mateos S and López-Lázaro M. (2013). Alpha beta-unsaturated lactones 2-furanone and 2-pyrone induce cellular DNA damage, formation of topoisomerase I-and II-DNA complexes and cancer cell death. Toxicology Letters 222(1): 64–71. https://doi. org/10.1016/j.toxlet.2013.07.007

Chang H S, Tang J Y, Yen C Y, Huang H W, Wu C Y, Chung Y A, Wang H R, Chen I S, Huang M Y and Chang H W. (2016). Anti-proliferation of Cryptocarya concinna-derived cryptocaryone against oral cancer cells involving apoptosis, oxidative stress, and DNA damage. BMC Complementary and Alternative Medicine 16(1): 94.

Com?a ?, Cimpean A M and Raica M. (2015). The story of MCF-7 breast cancer cell line: 40 years of experience in research. Anticancer Research 35: 3147–3154.

Corbin E A, Adeniba O O, Cangellaris O V, King W P and Bashir R. (2017). Evidence of differential mass change rates between human breast cancer cell lines in culture. Biomedical Microdevices 19(1): 10.

Dai X, Cheng H, Bai Z and Li J. (2017). Breast cancer cell line classification and its relevance with breast tumor subtyping. Journal of Cancer 8(16): 3131. https://doi. org/10.7150/jca.18457

Duronio R J and Xiong Y. (2013). Signalings pathways that control cell proliferation. Cold Spring Harbor Perspectives in Biology 5(3): a008904. cshperspect.a008904

Fairlamb I J, Marrison L R, Dickinson J M, Lu F J and Schmidt J P. (2004). 2-pyrones possessing antimicrobial and cytotoxic activities. Bioorganic & Medicinal Chemistry 12(15): 4285–4299.

Fan Y Liu Y, You Y X, Rao L, Su Y, He Q, Hu F, Li Y, Wei W, Xu Y K and Lin B. (2019). Cyto-toxic arylalkenyl ?, ?-unsaturated ?-lactones from Cryptocarya brachythyrsa. Fitoterapia 136: 104167.

Franken N A, Rodermond H M, Stap J, Haveman J and Van Bree C. (2006). Clonogenic assay of cells in vitro. Nature Protocols 1(5): 2315–2319. nprot.2006.339

Grigalius I and Petrikaite V. (2017). Relationships between antioxidant and anticancer activity of trihydroxyflavones. Molecules 22(12): 2169. molecules22122169

Giocondo M P, Bassi C L, Telascrea M, Cavalheiro A J, Bolzani V S, Silva D H, Agustoni D, Mello E R and Soares C P. (2009). Cryptomoschatone D2 from Cryptocarya mandioccana: Cytotoxicity against human cervical carcinoma cell lines. Revista de Ciências Farmacêuticas Básica e Aplicada 30(3): 315.

Hegde S M, Kumar M N, Kavya K, Kumar K K, Nagesh R, Patil R H and Sharma S C. (2016). Interplay of nuclear receptors (ER, PR, and GR) and their steroid hormones in MCF-7 cells. Molecular and Cellular Biochemistry 422: 109–120. https://doi. org/10.1007/s11010-016-2810-2

Hyun J, Woo Y, Hwang D S, Jo G, Eom S, Lee Y, Park J C and Lim Y. (2010) Relationships between structures of hydroxyflavones and their antioxidative effects. Bioorganic and Medicinal Chemistry Letters 20(18): 5510–5513. bmcl.2010.07.068

Juliawaty L D, Ra’idah P N, Abdurrahman S, Hermawati E, Alni A, Tan M I, Ishikawa H and Syah Y M. (2020). 5, 6-Dihydro-?-pyrones from the leaves of Cryptocarya pulchinervia (Lauraceae). Journal of Natural Medicines 23: 1–7. https://doi. org/10.1007/s11418-020-01397-7

Kaur R, Kapoor K and Kaur H. (2011). Plants as a source of anticancer agents. Journal of Natural Product and Plant Resources 1(1): 119–124.

Kurniadewi F, Juliawaty L D, Syah Y M, Achmad S A, Hakim E H, Koyama K, Kinoshita K and Takahashi K. (2010). Phenolic compounds from Cryptocarya konishii: Their cytotoxic and tyrosine kinase inhibitory properties. Journal of Natural Medicines 64(2): 121–125.

Mohapatra D K, Reddy D S, Ramaiah M J, Ghosh S, Pothula V, Lunavath S, Thomas S, Valli S P, Bhadra M P and Yadav J S. (2014). Rugulactone derivatives act as inhibitors of NF-?B activation and modulates the transcription of NF-?B dependent genes in MDA-MB-231 cells. Bioorganic & Medicinal Chemistry Letters 24(5): 1389–1396.

Raina H, Soni G, Jauhari N, Sharma N and Bharadvaja N. (2014). Phytochemical importance of medicinal plants as potential sources of anticancer agents. Turkish Journal of Botany 38(6): 1027–1035.

Ruijtenberg S and van den Heuvel S. (2016). Co-ordinating cell proliferation and differentiation: Antagonism between cell cycle regulators and cell type-specific gene expression. Cell Cycle 15(2): 196–212. 015.1120925

Scherer R and Godoy H T. (2009). Antioxidant activity index (AAI) by the 2, 2-diphenyl-1- picrylhydrazyl method. Food Chemistry 112(3): 654–658. foodchem.2008.06.026

Tungsukruthai S, Petpiroon N and Chanvorachote P. (2018). Molecular mechanisms of breast cancer metastasis and potential anti-metastatic compounds. Anticancer Research 38: 2607–2618.

Wu T S, Su C R and Lee K H. (2012). Cytotoxic and anti-HIV phenanthroindolizidine alkaloids from Cryptocarya chinensis. Natural Product Communications 7(6): 725–727.

Yu S, Kim T, Yoo K H and Kang K. (2017). The T47D cell line is an ideal experimental model to elucidate the progesterone-specific effects of a luminal A subtype of breast cancer. Biochemical and Biophysical Research Communications 486: 752–758.